Global Fund to Fight AIDS, Tuberculosis and Malaria: Takeda Makes First Private Sector Pledge for Global Fund Replenishment
“Takeda Pharmaceutical Company Limited today became the first private sector company to announce a financial commitment to the Global Fund’s Sixth Replenishment. The new pledge, consisting of JP ¥ 1 billion (approximately US$9 million) over five years, builds on Takeda’s previous contribution to the Global Fund. Takeda, a leading global pharmaceutical company headquartered in Japan, intends to support the improvement of maternal and child health by integrating quality HIV, tuberculosis, and malaria services in antenatal and postnatal care in several countries in Africa…” (6/3).